基金经理：楼慧源
| 单位净值:2.2018 | 净值增长率:0.83% | 累计净值:2.2018 | 截止日期:2024/6/11 | ||
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:3.67亿元 | 风险等级:高风险 | 申购状态:不可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
交银医药创新股票C(014046)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2024/3/31 | 231,534,000 | 166,870,000 | 26,453,600 | 91,117,800 | -64,664,200 | -27.93% |
| 2023/12/31 | 107,892,000 | 231,534,000 | 282,939,000 | 159,297,000 | 123,642,000 | 114.6% |
| 2023/12/31 | 89,178,400 | 231,534,000 | 163,061,000 | 20,705,900 | 142,355,100 | 159.63% |
| 2023/9/30 | 105,295,000 | 89,178,400 | 42,901,200 | 59,017,300 | -16,116,100 | -15.31% |
| 2023/6/30 | 107,892,000 | 105,295,000 | 76,976,300 | 79,574,200 | -2,597,900 | -2.41% |
| 2023/6/30 | 132,787,000 | 105,295,000 | 26,726,800 | 54,219,200 | -27,492,400 | -20.7% |
| 2023/3/31 | 107,892,000 | 132,787,000 | 50,249,500 | 25,355,000 | 24,894,500 | 23.07% |
| 2022/12/31 | 34,030,700 | 107,892,000 | 424,803,000 | 350,942,000 | 73,861,000 | 217.04% |
| 2022/12/31 | 169,987,000 | 107,892,000 | 60,646,600 | 122,741,000 | -62,094,400 | -36.53% |
| 2022/9/30 | 253,396,000 | 169,987,000 | 89,562,700 | 172,972,000 | -83,409,300 | -32.92% |
| 2022/6/30 | 34,030,700 | 253,396,000 | 274,594,000 | 55,228,600 | 219,365,400 | 644.61% |
| 2022/6/30 | 78,939,800 | 253,396,000 | 205,606,000 | 31,149,200 | 174,456,800 | 221% |
| 2022/3/31 | 34,030,700 | 78,939,800 | 68,988,500 | 24,079,400 | 44,909,100 | 131.97% |
| 2021/12/31 | 0 | 34,030,700 | 36,004,200 | 1,973,430 | 34,030,770 | INF% |
| 2021/12/31 | 0 | 34,030,700 | 36,004,200 | 1,973,430 | 34,030,770 | INF% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。